AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA
2.2450
31-January-25 11:42:36
15 minutes delayed
Stocks
+0.0450
+2.05%
Today's range
2.1703 - 2.2600
ISIN
N/A
Source
NASDAQ
-
Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
17 Jan 2025 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Provides Business Updates and 2025 Overview
13 Jan 2025 06:00:00 By Nasdaq GlobeNewswire
-
09 Dec 2024 18:30:00 By Nasdaq GlobeNewswire
-
02 Dec 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
12 Nov 2024 06:00:01 By Nasdaq GlobeNewswire
-
08 Nov 2024 15:23:24 By Nasdaq GlobeNewswire
-
05 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
28 Oct 2024 16:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
19 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
27 Aug 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
08 Aug 2024 06:00:01 By Nasdaq GlobeNewswire
-
26 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
31 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
17 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
13 May 2024 06:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 09:00:00 By Nasdaq GlobeNewswire
-
23 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >